Skip to content
healthcare.dev

XENPOZYME

NDC 58468-0051, olipudase alfa-rpcp, injection, powder, lyophilized, for solution, from Genzyme Corporation.

Product NDC
58468-0051
Status
Listed
Labeler
Genzyme Corporation
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761261
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0051 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLIPUDASE ALFA4 mg/1.1mL
Package NDCNDC-11Package
58468-0051-1584680051011 VIAL in 1 CARTON (58468-0051-1) / 1.1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/01a910ee-a33e-4be3-ac41-322d64c34311
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=58468-0051

Use it

Look up 58468-0051 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0051 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.